Robotic MRI-Ultrasound Fusion Biopsy Clinical Evidence

The robotic MRI-ultrasound fusion biopsy clinical evidence from the prospective 48‑patient Antalya study demonstrates a 47.9% overall cancer detection rate, 91.7% detection in PI‑RADS 5 lesions, and two anterior‑zone cancers found only by the robotic method. Published in JVIR with a Cohen's Kappa of 0.916, this evidence validates the platform's ability to detect cancers that systematic biopsy routinely misses.